Abstract | BACKGROUND: METHODS: Sixty Wistar albino female rats weighing 230±20 g were included, with 10 rats in each group: group early c (early control): 3 mL isotonic saline; group early l1.25 (early levobupivacaine 1.25): 1.25 mg/kg per 3 mL levobupivacaine; group early l2.5 (early levobupivacaine 2.5): 2.5 mg/kg per 3 mL levobupivacaine; group late c (late control): 3 mL isotonic saline; group late l1.25 (late levobupivacaine 1.25): 1.25 mg/kg per 3 mL levobupivacaine; and group late l2.5 (late levobupivacaine 2.5): 2.5 mg/kg per 3 mL levobupivacaine. Rats in groups early c to early l2.5 were euthanized on the 8th day. Rats in groups late c to late l2.5 were euthanized on the 21st day. Wound tension strength, tissue hydroxyproline, and fibrotic index levels of the tissue samples from the early c and early l2.5 and late c and late l2.5 groups, respectively, on the 8th and 21st days were examined. RESULTS:
Levobupivacaine decreased wound tension strength on the 8th day, especially a 2.5 mg/kg dose (P<0.001), and increased it on the 21st day (P<0.001). It also increased the inflammatory response (P<0.001) and collagen synthesis (8th day, P=0.109; 21st day, P=0.103) on both the 8th and 21st days. CONCLUSIONS: While levobupivacaine had a positive effect on wound healing during the early period, negative effects were observed thereafter. Additional studies at the molecular level are necessary to determine the cause of these apparently opposite effects.
|
Authors | Sezgin Zeren, Sevgi Kesici, Ugur Kesici, Salim Isbilir, Ulku Aygen Turkmen, Hulya Ulusoy, Vildan Karpuz, Omer Ozcan, Erdal Polat, Osman Metin Ipcioglu, Musa Kazim Sari |
Journal | Anesthesia and analgesia
(Anesth Analg)
Vol. 116
Issue 2
Pg. 495-9
(Feb 2013)
ISSN: 1526-7598 [Electronic] United States |
PMID | 23302982
(Publication Type: Journal Article)
|
Chemical References |
- Anesthetics, Local
- Levobupivacaine
- Hydroxyproline
- Bupivacaine
|
Topics |
- Anesthetics, Local
(adverse effects, therapeutic use)
- Animals
- Biopsy
- Bupivacaine
(adverse effects, analogs & derivatives, therapeutic use)
- Cell Proliferation
- Female
- Fibrosis
- Hydroxyproline
(analysis, metabolism)
- Levobupivacaine
- Postoperative Period
- Rats
- Rats, Wistar
- Skin
(chemistry)
- Sutures
- Tensile Strength
- Wound Healing
(drug effects)
- Wounds and Injuries
(metabolism, pathology)
|